종양학 정보 시스템 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Oncology Information Systems Market Size, Share & Trends Analysis Report By Products & Services (Solutions, Professional Services), By Application (Medical Oncology, Surgical Oncology), By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,269,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,659,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,438,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

종양학 정보 시스템 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 종양학 정보 시스템 시장 규모는 2030년까지 46억 9,000만 달러에 달할 것으로 추정되며, 2025-2030년에 걸쳐 CAGR 8.1%를 나타낼 것으로 예측됩니다.

세계의 암의 유병률이 증가하고 있는 것, 주요 기업에 의한 암 연구에 관한 제품 개발에 대한 투자가 증가하고 있는 것이 시장 성장의 주요 촉진요인입니다. HPV와 간염과 같은 암을 일으키는 감염증은 중저소득국가에서 증례의 약 30%를 일으키고 있습니다.

정부와 주요 기업에 의한 종양학 부문에 대한 투자 증가는 시장 성장을 뒷받침하는 중요한 요인 중 하나입니다. 미국 정부는 암 문샷에 1억 9,400만 달러를, 소아암 데이터 이니셔티브에 5천만 달러를 2022년 한 해 동안 배정했습니다. 시장 각사는 제품 개발을 강화하고 사업 영역을 확대하기 위해 협력하고 있습니다. 예를 들어, 2020년 Accuray Inc. Inc.가 AI 정보학 기업인 VieCure와 제휴해, 개별화 암 치료의 도입을 강화하는 솔루션을 개발했습니다. 이러한 요인이 시장 성장을 가속할 것으로 예측됩니다.

제품 및 서비스 부문 솔루션은 2024년에 가장 큰 시장 점유율을 차지했으며, 환자 데이터 관리와 다른 의료 시설 간의 데이터 공유를 위한 솔루션의 채택이 증가함에 따라 시장 급성장의 주요 원인이 되었습니다. 의료 현장에서 숙련된 전문가의 부족으로 OIS 소프트웨어 관리의 전문 서비스와 아웃소싱의 동향이 활발해지고 있는 것도 시장의 성장을 뒷받침하고 있습니다.

면역요법, 방사선요법, 특정 암에 대한 표적요법의 혁신이 시장 성장을 견인하고 있습니다. 현장이 되었습니다. 정교한 의료 시스템과 환자 데이터의 적절한 관리의 중요성에 대한 높은 의식도 이 지역 시장 성장으로 이어지고 있습니다.

종양학 정보 시스템 시장 보고서 하이라이트

• 솔루션부문이 2024년의 수익 점유율 73.99%로 시장을 독점했고, 예측 기간 중에 가장 빠른 CAGR을 나타낼 것으로 예측됩니다.
• 의료 종양학 부문이 2024년에 61.81%의 최대 매출 점유율을 차지했고, 2025-2030년에 걸쳐 가장 빠른 CAGR을 나타낼 것으로 예측됩니다.
• 병원·영상 진단센터 부문은 2024년에 47.53%의 최대 수익 점유율을 차지했습니다.
• 북미의 종양학 정보 시스템 시장은 2024년에 39.67%의 최대 매출 점유율을 차지했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

• 시장 계통의 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 산업의 과제 분석
  • 이용 사례
• 비즈니스 환경 분석
  • Porter's Five Forces 분석
  • PESTLE 분석

제4장 종양학 정보 시스템 시장 : 제품 및 서비스별, 추정 및 동향 분석

• 제품 및 서비스 부문 대시보드
• 제품 및 서비스 시장 점유율 변동 분석(2024년, 2030년)
• 시장 규모, 예측, 동향 분석 - 제품 및 서비스별(2018-2030년)
• 솔루션
  • 솔루션 시장(2018-2030년)
  • 환자 정보 시스템
  • 치료 계획 시스템
• 전문 서비스
  • 전문 서비스 시장(2018-2030년)

제5장 종양학 정보 시스템 시장 : 용도별, 추정 및 동향 분석

• 용도 부문 대시보드
• 용도 시장 점유율 변동 분석(2024년, 2030년)
• 시장 규모, 예측, 동향 분석 - 용도별(2018-2030년)
• 의료 종양학
  • 의료 종양학 시장(2018-2030년)
• 방사선 종양학
  • 방사선 종양학 시장(2018-2030년)
• 외과 종양학
  • 외과 종양학 시장(2018-2030년)

제6장 종양학 정보 시스템 시장 : 최종 용도별, 추정 및 동향 분석

• 최종 용도 부문 대시보드
• 최종 용도 시장 점유율 변동 분석(2024년, 2030년)
• 시장 규모, 예측, 동향 분석 - 최종 용도별(2018-2030년)
• 병원 및 진단 영상 센터
  • 병원 및 진단 영상 센터 시장(2018-2030년)
• 절제 치료 센터 및 암 치료 센터
  • 절제 치료 센터 및 암 치료 센터 시장(2018-2030년)
• 정부기관
  • 정부기관 시장(2018-2030년)
• 연구시설
  • 연구시설 시장(2018-2030년)

제7장 종양학 정보 시스템 시장 : 지역별, 추정 및 동향 분석

• 지역별 시장 대시보드
• 지역 시장 : 주요 포인트
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 참가자 개요
• 기업의 시장 포지셔닝 분석
• 기업 분류
• 전략 매핑
• 기업 프로파일/상장 기업
  • Accuray Incorporated
  • Elekta
  • Prowess, Inc.
  • BrainLab
  • DOSIsoft SA
  • FLATIRON HEALTH
  • RaySearch Laboratories
  • Oracle(Cerner Corporation)
  • Koninklijke Philips NV
  • Varian Medical Systems, Inc.(Siemens Healthineers)

KTH

영문 목차

영문목차

Oncology Information Systems Market Growth & Trends:

The global oncology information systems market size is estimated to reach USD 4.69 billion by 2030, registering to grow at a CAGR of 8.1% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing prevalence of cancer around the globe and rising investment in product development about cancer research undertaken by key players are key driving factors for the growth of the market. According to the estimates published by GLOBOCAN in 2020, 19.3 million new cancer cases were diagnosed and 10.0 million cancer-related mortalities were recorded. Cancer-causing infections like HPV and Hepatitis cause approximately 30% of cases in low-middle-income nations. The growing cancer burden is expected to boost the demand for advanced cancer care & management therapies with accurate and efficient results, thereby aiding the market growth.

Increasing investments in the field of oncology by both governments as well as key players is one of the key factors for boosting the market growth. The U.S. government has allocated $194 million towards Cancer Moonshot and $50 million to Childhood Cancer Data Initiative for the year 2022. Market players are collaborating to enhance product development and expand their business footprint. For instance, in 2020 Accuray Inc. collaborated with Brainlab, a German digital surgery company, to expand Accuray's CyberKnife platform treatment abilities for the neuro-radiosurgery sector. In 2020, ViewRay Inc. collaborated with VieCure, an AI informatics company, to develop solutions to enhance the adoption of personalized cancer care. These factors are expected to drive market growth.

Solutions in the product & services segment held the largest market share in 2024. The rising adoption of solutions for patient data management and data sharing across different healthcare facilities is primarily responsible for the momentous growth of the market. The OIS solutions are aimed at better management practices as well as providing better treatment courses for optimal patient outcomes. An uptick in the trend for professional services or outsourcing of OIS software management, due to the lack of skilled professionals in the healthcare settings, is also helping the market growth. The medical oncology application segment held the largest market share in 2024. It is also estimated to be the fastest-growing segment from 2025 to 2030.

Innovations in immunotherapy, radiotherapy as well as targeted therapy for specific cancers have led the market growth. The surgical oncology segment is also expected to witness significant growth owing to technological advancements in the field of surgical interventions related to the treatment of various cancers. North America was the largest regional market in 2024 owing to the presence of major players. The sophisticated healthcare system and high awareness of the importance of proper management of patient data have also led to regional market growth. Asia Pacific is projected to be the fastest-growing regional market due to rising expenditure on healthcare IT and overall healthcare facilities and supportive government initiatives

Oncology Information Systems Market Report Highlights:

• The solutions segment dominated the market with a revenue share of 73.99% in 2024 and is expected to grow at the fastest CAGR during the forecast period.
• The medical oncology segment accounted for the largest revenue share of 61.81% in 2024 and is projected to grow at the fastest CAGR from 2025 to 2030.
• The hospitals & diagnostic imaging centers segment held the largest revenue share of 47.53% in 2024.
• North America oncology information systems market held the largest revenue share of 39.67% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Products & Services
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of cancer
    • 3.2.1.2. Increasing investments and strategic initiatives in radiology and oncology
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Cybersecurity and privacy concerns
    • 3.2.2.2. Shortage of healthcare personnel in information technology
  • 3.2.3. Industry Challenge Analysis
  • 3.2.4. Case Studies
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Oncology Information Systems Market: Products & Services Estimates & Trend Analysis

• 4.1. Products & Services Segment Dashboard
• 4.2. Products & Services Market Share Movement Analysis, 2024 & 2030
• 4.3. Market Size & Forecasts and Trend Analysis, by Products & Services, 2018 to 2030 (USD Million)
• 4.4. Solutions
  • 4.4.1. Solutions market, 2018 - 2030 (USD Million)
  • 4.4.2. Patient Information Systems
    • 4.4.2.1. Patient information systems market, 2018 - 2030 (USD Million)
  • 4.4.3. Treatment Planning Systems
    • 4.4.3.1. Treatment planning systems market, 2018 - 2030 (USD Million)
• 4.5. Professional Services
  • 4.5.1. Professional Services market, 2018 - 2030 (USD Million)

Chapter 5. Oncology Information Systems Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Application Market Share Movement Analysis, 2024 & 2030
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Medical Oncology
  • 5.4.1. Medical oncology market, 2018 - 2030 (USD Million)
• 5.5. Radiation Oncology
  • 5.5.1. Radiation oncology market, 2018 - 2030 (USD Million)
• 5.6. Surgical Oncology
  • 5.6.1. Surgical oncology market, 2018 - 2030 (USD Million)

Chapter 6. Oncology Information Systems Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. End Use Market Share Movement Analysis, 2024 & 2030
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals & Diagnostic Imaging Centers
  • 6.4.1. Hospitals & diagnostic imaging centers market, 2018 - 2030 (USD Million)
• 6.5. Ablation Care Centers & Cancer Care Centers
  • 6.5.1. Ablation care centers and cancer care centers market, 2018 - 2030 (USD Million)
• 6.6. Government Institutions
  • 6.6.1. Government institutions market, 2018 - 2030 (USD Million)
• 6.7. Research Facilities
  • 6.7.1. Research facilities market, 2018 - 2030 (USD Million)

Chapter 7. Oncology Information Systems Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market: Key Takeaways
• 7.3. North America
  • 7.3.1. North America oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamic
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive insights
    • 7.3.2.4. U.S. oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamic
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive insights
    • 7.3.3.4. Canada oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamic
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive insights
    • 7.3.4.4. Mexico oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamic
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. Germany oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. UK
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. UK oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. France oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamic
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive insights
    • 7.4.5.4. Italy oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamic
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive insights
    • 7.4.6.4. Spain oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamic
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive insights
    • 7.4.7.4. Denmark oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamic
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive insights
    • 7.4.8.4. Sweden oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamic
    • 7.4.9.2. Regulatory framework
    • 7.4.9.3. Competitive insights
    • 7.4.9.4. Norway oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamic
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. Japan oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. China oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. India oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. South Korea oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Australia oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Thailand oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Oncology Information Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamic
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Brazil oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamic
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. Argentina oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamic
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. South Africa oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Saudi Arabia oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamic
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive insights
    • 7.7.4.4. UAE oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamic
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive insights
    • 7.7.5.4. Kuwait oncology information systems market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Accuray Incorporated
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Products & Services benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Elekta
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Products & Services benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Prowess, Inc.
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Products & Services benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. BrainLab
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Products & Services benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. DOSIsoft SA
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Products & Services benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. FLATIRON HEALTH
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Products & Services benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. RaySearch Laboratories
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Products & Services benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Oracle (Cerner Corporation)
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Products & Services benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Koninklijke Philips N.V.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Products & Services benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Varian Medical Systems, Inc. (Siemens Healthineers)
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Products & Services benchmarking

관련자료